Abstract | OBJECTIVE: METHODS: We serially tested for aCL in a standardized fashion in patients with scleroderma who were outpatients and gave consent to enter this study. RESULTS: CONCLUSION: aCL in scleroderma rarely manifest clinically. The range of frequency of positive aCL in the literature is from 0 to 63%. From our study and the literature, we cannot ascertain if the prevalence is different in limited and diffuse scleroderma.
|
Authors | J E Pope, A Thompson |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 27
Issue 6
Pg. 1450-2
(Jun 2000)
ISSN: 0315-162X [Print] Canada |
PMID | 10852269
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Anticardiolipin
|
Topics |
- Adult
- Aged
- Antibodies, Anticardiolipin
(blood)
- Female
- Humans
- Middle Aged
- Scleroderma, Systemic
(epidemiology, immunology)
- Seroepidemiologic Studies
|